Hyoscine Butylbromide EP Impurity I |
Hyoscine Butylbromide EP Impurity I |
2030294-83-6 |
Isavuconazole Impurity 2 |
Isavuconazole Impurity 2 |
2001051-99-4 |
13-Ethyl-17-hydroxy-18,19-dinorpregn-5(10)-en-20-yn-3-one |
13-乙基-17Β-羟基-18,19-二去甲孕甾-5(10)-烯-20-炔-3-酮 17Α-乙炔基-17Β-羟基-18-甲基雌甾-5(10)-烯-3-酮 |
19914-67-1 |
DMBAP |
DMBAP |
190910-14-6 |
CEMBRENE |
西柏烯 |
1898-13-1 |
Ambroxol EP Impurity B |
氨溴索杂质B |
18683-95-9 |
2,3-Dihydro-2,3,4,6,7-pentamethyl-2-(4,8,12-trimethyltridecyl)-5-benzofuranol |
生育酚杂质1 |
185672-33-7 |
Levalbuterol Related Compound G (20 mg) (alpha[{(1,1-Dimethylethyl)amino}methyl]-4,5-dihydroxy-1,3-benzenedimethanol) |
左沙丁胺醇相关物质G |
182676-90-0 |
5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine |
帕布昔利布杂质 |
1823404-28-9 |
PeMetrexed EP IMpurity E |
培美曲塞杂质E |
182009-04-7 |
11-Deoxy Prednisolone |
泼尼松龙EP杂质J |
1807-14-3 |
Cefdinir Related Compound A (10 mg) (2(R)-2-[(Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido]-2-[(2RS,5RS)-5-methyl-7-oxo-2,4,5,7-tetrahydro-1Hfuro[3,4-d][1,3]thiazin-2-yl]acetic acid) |
头孢地尼相关化合物A |
178422-42-9 |
cis-Terbinafine Hydrochloride |
特布他林相关物质B |
176168-78-8 |
Dehydro Olmesartan |
脱氢奥美沙坦酯 |
172875-98-8 |
ent-Aprepitant |
ENT-阿瑞匹坦 |
172822-29-6 |
Metoclopramide N-Oxide |
甲氧氯普安N氧化物 |
171367-22-9 |
LINCOMYCIN HYDROCHLORIDE |
林可霉素 |
17017-22-0 |
Dipyridamole Tripiperidine |
双嘧达莫杂质A |
16982-40-4 |
Dipyridamole Tri(diethanolamine) |
双嘧达莫杂质B |
16908-47-7 |
(3E,5E,7E)-9-[(3E)-2,4,4-Trimethyl-1-cyclohexen-3-ylidene]-3,7-dimethylnona-3,5,7-trien-1-ol |
维生素A杂质C |
16729-22-9 |